<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34546419</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-198X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric nephrology (Berlin, Germany)</Title>
          <ISOAbbreviation>Pediatr Nephrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Posterior reversible leukoencephalopathy syndrome associated with acute postinfectious glomerulonephritis: systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>833</StartPage>
          <EndPage>841</EndPage>
          <MedlinePgn>833-841</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00467-021-05244-z</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Kidney diseases are a recognized cause of posterior reversible leukoencephalopathy syndrome, usually abbreviated as PRES. The purpose of this review was to systematically address the association between acute postinfectious glomerulonephritis and PRES.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review of the literature on acute postinfectious glomerulonephritis associated with PRES. The principles recommended by the Economic and Social Research Council guidance on the conduct of narrative synthesis and on the Preferred Reporting Items for Systematic Reviews and Meta-analyses were used. Databases searched included Excerpta Medica, US National Library of Medicine, and Web of Science.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">For the final analysis, we evaluated 47 reports describing 52 cases (32 males and 20 females). Fifty patients were ≤ 18 years of age. Blood pressure was classified as follows: normal-elevated (n = 3), stage 1 hypertension (n = 3), stage 2 hypertension (n = 5), and severe hypertension (n = 41). Acute kidney injury was classified as stage 1 in 32, stage 2 in 16, and stage 3 in four cases. Neuroimaging studies disclosed a classic posterior PRES pattern in 28 cases, a diffuse PRES pattern in 23 cases, and a brainstem-cerebellum PRES pattern in the remaining case. Antihypertensive drugs were prescribed in all cases and antiepileptic drugs in cases presenting with seizures. A resolution of clinical findings and neuroimaging lesions was documented in all cases with information about follow-up.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The main factor associated with PRES in acute postinfectious glomerulonephritis is severe hypertension. Prompt clinical suspicion, rapid evaluation, and management of hypertension are crucial. A higher resolution version of the Graphical abstract is available as Supplementary information.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Orlando</LastName>
            <ForeName>Corinne</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Family Medicine Institute, Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Milani</LastName>
            <ForeName>Gregorio P</ForeName>
            <Initials>GP</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences and Community Health, Università Degli Studi Di Milano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simonetti</LastName>
            <ForeName>Giacomo D</ForeName>
            <Initials>GD</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Institute of Southern Switzerland EOC, Ospedale San Giovanni, Bellinzona, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goeggel Simonetti</LastName>
            <ForeName>Barbara</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Institute of Southern Switzerland EOC, Ospedale San Giovanni, Bellinzona, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, University Hospital Bern, University of Bern, Bern, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lava</LastName>
            <ForeName>Sebastiano A G</ForeName>
            <Initials>SAG</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wyttenbach</LastName>
            <ForeName>Rolf</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Imaging Institute of Southern Switzerland EOC, Bellinzona, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Diagnostic, Interventional and Pediatric Radiology (DIPR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bianchetti</LastName>
            <ForeName>Mario G</ForeName>
            <Initials>MG</Initials>
            <Identifier Source="ORCID">0000-0003-4827-6973</Identifier>
            <AffiliationInfo>
              <Affiliation>Family Medicine Institute, Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland. mario.bianchetti@usi.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland. mario.bianchetti@usi.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cristallo Lacalamita</LastName>
            <ForeName>Marirosa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Imaging Institute of Southern Switzerland EOC, Bellinzona, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>09</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pediatr Nephrol</MedlineTA>
        <NlmUniqueID>8708728</NlmUniqueID>
        <ISSNLinking>0931-041X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005921" MajorTopicYN="Y">Glomerulonephritis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054038" MajorTopicYN="Y">Posterior Leukoencephalopathy Syndrome</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acute brain capillary leak syndrome</Keyword>
        <Keyword MajorTopicYN="N">Acute postinfectious glomerulonephritis</Keyword>
        <Keyword MajorTopicYN="N">Acute poststreptococcal glomerulonephritis</Keyword>
        <Keyword MajorTopicYN="N">Hypertensive encephalopathy</Keyword>
        <Keyword MajorTopicYN="N">Posterior reversible leukoencephalopathy syndrome</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>21</Day>
          <Hour>12</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34546419</ArticleId>
        <ArticleId IdType="pmc">PMC8960599</ArticleId>
        <ArticleId IdType="doi">10.1007/s00467-021-05244-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s00467-021-05244-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500. doi: 10.1056/NEJM199602223340803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199602223340803</ArticleId>
            <ArticleId IdType="pubmed">8559202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levitt A, Zampolin R, Burns J, Bello JA, Slasky SE. Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: distinct clinical entities with overlapping pathophysiology. Radiol Clin North Am. 2019;57:1133–1146. doi: 10.1016/j.rcl.2019.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rcl.2019.07.001</ArticleId>
            <ArticleId IdType="pubmed">31582040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milani GP, Bianchetti MG, Mazzoni MB, Triulzi F, Mauri MC, Agostoni C, Fossali EF. Arterial hypertension and posterior reversible cerebral edema syndrome induced by risperidone. Pediatrics. 2014;133:e771–e774. doi: 10.1542/peds.2013-1301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2013-1301</ArticleId>
            <ArticleId IdType="pubmed">24567018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fux CA, Bianchetti MG, Jakob SM, Remonda L. Reversible encephalopathy complicating post-streptococcal glomerulonephritis. Pediatr Infect Dis J. 2006;25:85–87. doi: 10.1097/01.inf.0000195614.66987.2f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.inf.0000195614.66987.2f</ArticleId>
            <ArticleId IdType="pubmed">16395114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milani GP, Edefonti A, Tardini G, Arturi E, Cinnante CM, Laicini EA, Leva E, Cappellari AM, Agostoni C, Fossali EF. Severe and isolated headache associated with hypertension as unique clinical presentation of posterior reversible encephalopathy syndrome. BMC Pediatr. 2014;14:190. doi: 10.1186/1471-2431-14-190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2431-14-190</ArticleId>
            <ArticleId IdType="pmc">PMC4113662</ArticleId>
            <ArticleId IdType="pubmed">25062701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanDeVoorde RG., 3rd Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis. Pediatr Rev. 2015;36:3–13. doi: 10.1542/pir.36-1-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/pir.36-1-3</ArticleId>
            <ArticleId IdType="pubmed">25554106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunt EAK, Somers MJG (2019) Infection-related glomerulonephritis. Pediatr Clin North Am 66:59–72. 10.1016/j.pcl.2018.08.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30454751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65–W94. doi: 10.7326/0003-4819-151-4-200908180-00136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00136</ArticleId>
            <ArticleId IdType="pubmed">19622512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group  KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138. doi: 10.1038/kisup.2012.1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM; Subcommittee on screening and management of high blood pressure in children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. 10.1542/peds.2017-1904</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28827377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simonetti GD, Santoro L, Ferrarini A, Crosazzo-Franscini L, Fossali E, Bianchetti MG; CHILD Project  Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. Paediatr Drugs. 2007;9:413–418. doi: 10.2165/00148581-200709060-00008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00148581-200709060-00008</ArticleId>
            <ArticleId IdType="pubmed">18052411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J Stroke Cerebrovasc Dis. 2012;21:873–882. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2011.05.010</ArticleId>
            <ArticleId IdType="pubmed">21703874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brady E, Parikh NS, Navi BB, Gupta A, Schweitzer AD. The imaging spectrum of posterior reversible encephalopathy syndrome: a pictorial review. Clin Imaging. 2018;47:80–89. doi: 10.1016/j.clinimag.2017.08.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinimag.2017.08.008</ArticleId>
            <ArticleId IdType="pubmed">28910681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaplan RA, Zwick DL, Hellerstein S, Warady BA, Alon U. Cerebral vasculitis in acute post-streptococcal glomerulonephritis. Pediatr Nephrol. 1993;7:194–195. doi: 10.1007/BF00864396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00864396</ArticleId>
            <ArticleId IdType="pubmed">8476718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saatçi I, Topaloğlu R. Cranial computed tomographic findings in a patient with hypertensive encephalopathy in acute poststreptococcal glomerulonephritis. Turk J Pediatr. 1994;36:325–328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7825239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nordby JA. Neurological presentation of poststreptococcal glomerulonephritis. Clin Pediatr (Phila) 1997;36:105–108. doi: 10.1177/000992289703600207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/000992289703600207</ArticleId>
            <ArticleId IdType="pubmed">9118587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rovang RD, Zawada ET, Jr, Santella RN, Jaqua RA, Boice JL, Welter RL. Cerebral vasculitis associated with acute post-streptococcal glomerulonephritis. Am J Nephrol. 1997;17:89–92. doi: 10.1159/000169077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000169077</ArticleId>
            <ArticleId IdType="pubmed">9057959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Froehlich T, Sandifer S, Varma PK, Testa FM. Two cases of hypertension-induced reversible posterior leukoencephalopathy syndrome secondary to glomerulonephritis. Curr Opin Pediatr. 1999;11:512–518. doi: 10.1097/00008480-199912000-00007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00008480-199912000-00007</ArticleId>
            <ArticleId IdType="pubmed">10590909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soylu A, Kavukçu S, Türkmen M, Akbaş Y. Posterior leukoencephalopathy syndrome in poststreptococcal acute glomerulonephritis. Pediatr Nephrol. 2001;16:601–603. doi: 10.1007/s004670100601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s004670100601</ArticleId>
            <ArticleId IdType="pubmed">11465812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caramés Bartolomé E, Rodrigues Sousa C, Morais Barbosa C. Leucoencefalopatía posterior reversible secundaria a glomerulonephritis [Reversible posterior leukoencephalopathy secondary to glomerulonephritis] An Esp Pediatr. 2002;56:474–476. doi: 10.1016/S1695-4033(02)77850-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1695-4033(02)77850-8</ArticleId>
            <ArticleId IdType="pubmed">12042126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casali-Rey JI, Dávalos EG, López-Amalfara A, Julio-Muñoz D, Pagano MA. Sindrome de encefalopatía posterior reversible: presentación de casos clínicos [Posterior reversible encephalopathy syndrome: some case reports] Rev Neurol. 2003;37:224–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12938054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang MH, Sheu JN, Wang SJ. Cortical blindness in a boy with acute glomerulonephritis. J Formos Med Assoc. 2003;102:52–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12684614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Özçakar ZB, Ekim M, Fitoz S, Teber S, Hizel S, Acar B, Yüksel S, Yalcinkaya F. Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr. 2004;163:728–730. doi: 10.1007/s00431-004-1532-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00431-004-1532-8</ArticleId>
            <ArticleId IdType="pubmed">15322868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bazzino F, Pandolfo S, Protasio L, Pujadas M, Cerisola A, González G, Caggiani M, Rubio I. Leucoencefalopatía posterior reversible secundaria a glomerulonefritis postestreptocócica: a propósito de un caso [Posterior reversible leukoencephalopathy syndrome associated with poststreptococcal postinfectious glomerulonephritis: case report] Arch Pediatr Urug. 2005;76:228–233.</Citation>
        </Reference>
        <Reference>
          <Citation>Lizarazo J, Tibasosa D, Alandete S. Síndrome de encefalopatía posterior reversible [Posterior reversible encephalopathy syndrome] Acta Neurol Colomb. 2005;21:289–298.</Citation>
        </Reference>
        <Reference>
          <Citation>Ohtomo Y, Takada M, Fujinaga S, Murakami H, Yamashiro Y. Hypertensive encephalopathy in a boy with biopsy-proven acute post-streptococcal glomerulonephritis. Pediatr Int. 2005;47:323–325. doi: 10.1111/j.1442-200x.2005.02071.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-200x.2005.02071.x</ArticleId>
            <ArticleId IdType="pubmed">15910459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aeby A, David P, Fricx C, Jissendi P, Blecic S, Van Bogaert P. Posterior reversible encephalopathy syndrome revealing acute post-streptococcal glomerulonephritis. J Child Neurol. 2005;21:250–251. doi: 10.2310/7010.2006.00057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2310/7010.2006.00057</ArticleId>
            <ArticleId IdType="pubmed">16901429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, Nishimura G, Hiramoto R, Honda M. Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis. 2006;8:231–238. doi: 10.1053/j.ajkd.2006.04.076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2006.04.076</ArticleId>
            <ArticleId IdType="pubmed">16860188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritt M, Campean V, Amann K, Heider A, Griesbach D, Veelken R. Transient encephalopathy complicating poststreptococcal glomerulonephritis in an adult with diagnostic findings consistent with cerebral vasculitis. Am J Kidney Dis. 2006;48:489–494. doi: 10.1053/j.ajkd.2006.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2006.06.004</ArticleId>
            <ArticleId IdType="pubmed">16931224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ram R, Swarnalatha G, Prasad N, Dakshinamurty KV. Glomerulonephritis and altered mental status. Kidney Int. 2007;72:1413–1414. doi: 10.1038/sj.ki.5002542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.ki.5002542</ArticleId>
            <ArticleId IdType="pubmed">18004316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wirrell EC, Hamiwka LD, Hamiwka LA, Grisaru S, Wei X. Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci. 2007;34:316–321. doi: 10.1017/s0317167100006740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/s0317167100006740</ArticleId>
            <ArticleId IdType="pubmed">17803029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dursun I, Gunduz Z, Poyrazoglu HM, Gumus H, Yikilmaz A, Dusunsel R. Cerebral vasculitis and unilateral sixth-nerve palsy in acute post-streptococcal glomerulonephritis. Ann Trop Paediatr. 2008;28:155–159. doi: 10.1179/146532808X302198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1179/146532808X302198</ArticleId>
            <ArticleId IdType="pubmed">18510827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pashankar FD, Ment LR, Pearson HA. Sickle cell disease complicated by post-streptococcal glomerulonephritis, cerebral hemorrhage and reversible posterior leucoencephalopathy syndrome. Pediatr Blood Cancer. 2008;50:864–866. doi: 10.1002/pbc.21321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.21321</ArticleId>
            <ArticleId IdType="pubmed">17973321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bekmezian A, Lasky JL, 3rd, Osman S, Kaddurah AK, Varela AM, Velez K, Alvarez O. Index of suspicion. Pediatr Rev. 2009;30:311–316. doi: 10.1542/pir.30-8-311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/pir.30-8-311</ArticleId>
            <ArticleId IdType="pubmed">19648262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta S, Goyal VK, Talukdar B. Reversible posterior leucoencephalopathy syndrome in post streptococcal glomerulonephritis. Indian Pediatr. 2010;47:274–276. doi: 10.1007/s13312-010-0037-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13312-010-0037-y</ArticleId>
            <ArticleId IdType="pubmed">20371895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gümüş H, Per H, Kumandaş S, Yikilmaz A. Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. Neurol Sci. 2010;31:125–131. doi: 10.1007/s10072-009-0158-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-009-0158-z</ArticleId>
            <ArticleId IdType="pubmed">19809787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychogios MN, Schramm P, Knauth M. Reversibles Enzephalopathie-Syndrom, RES oder PRES: ein Fall mit mehr W (watershed) als P (posterior)! [Reversible encephalopathy syndrome, RES or PRES: a case with more W (watershed) than P (posterior)!] Röfo. 2010;182:76–79. doi: 10.1055/s-0028-1109778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0028-1109778</ArticleId>
            <ArticleId IdType="pubmed">19862660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berdai AM, Harandou M. Une encéphalopathie postérieure réversible révélant une glomérulonéphrite post infectieuse [A posterior reversible encephalopathy revealing post infectious glomerulonephritis] Pan Afr Med J. 2012;13:82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3567421</ArticleId>
            <ArticleId IdType="pubmed">23396901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endo A, Fuchigami T, Hasegawa M, Hashimoto K, Fujita Y, Inamo Y, Mugishima H. Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature. Pediatr Emerg Care. 2012;28:153–157. doi: 10.1097/PEC.0b013e3182442fe8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PEC.0b013e3182442fe8</ArticleId>
            <ArticleId IdType="pubmed">22307182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grimminck B, de Jong H, Sluzewski M, Obihara CC. Een kind met onbegrepen convulsies: posterieur reversibel encefalopathiesyndroom [A child with convulsions of unknown origin: posterior reversible encephalopathy syndrome] Ned Tijdschr Geneeskd. 2012;156:A3920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22531039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaarthigeyan K, Vijayalakshmi AM. Cortical blindness in a child with acute glomerulonephritis. Indian J Nephrol. 2012;22:42–44. doi: 10.4103/0971-4065.86408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0971-4065.86408</ArticleId>
            <ArticleId IdType="pmc">PMC3263062</ArticleId>
            <ArticleId IdType="pubmed">22279342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ortiz A, Elsässer S, Roverano S, Paira S. Síndrome de encefalopatía posterior reversible (PRES): comunicación de tres casos [Posterior reversible encephalopathy syndrome: a report of three cases] Rev Argent Reumatol. 2012;23:52–60.</Citation>
        </Reference>
        <Reference>
          <Citation>Alves GRT, Cordenonsi ICO, Silva RVA, Haygert CJP. Posterior reversible encephalopathy syndrome following post-streptococcal glomerulonephritis. Banglad J Med Sci. 2013;12:341–343. doi: 10.3329/bjms.v12i3.13323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3329/bjms.v12i3.13323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dasgupta MK, Sarkar S, Patra C (2013) Posterior reversible encephalopathy syndrome in a case of post-streptococcal glomerulonephritis. J Pediatr Sci 5:e1192</Citation>
        </Reference>
        <Reference>
          <Citation>Sfaihi L, Kamoun F, Hentati Y, Tiss O, Maaloul I, Kamoun T, Mnif Z, Hachicha M. Syndrome d’encéphalopathie postérieure réversible induit par une glomérulonéphrite aiguë postinfectieuse [Posterior reversible encephalopathy syndrome induced by acute postinfectious glomerulonephritis] Arch Pédiatr. 2013;20:633–636. doi: 10.1016/j.arcped.2013.03.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arcped.2013.03.014</ArticleId>
            <ArticleId IdType="pubmed">23619208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adikari M, Priyangika D, Marasingha I, Thamotheram S, Premawansa G. Post-streptococcal glomerulonephritis leading to posterior reversible encephalopathy syndrome: a case report. BMC Res Notes. 2014;7:644. doi: 10.1186/1756-0500-7-644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-0500-7-644</ArticleId>
            <ArticleId IdType="pmc">PMC4175190</ArticleId>
            <ArticleId IdType="pubmed">25218027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akın F, Kılıçaslan C, Solak ES, Uzun M, Aygün S, Arslan Ş. Posterior reversible encephalopathy syndrome in children: report of three cases. Childs Nerv Syst. 2014;30:535–540. doi: 10.1007/s00381-013-2342-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00381-013-2342-y</ArticleId>
            <ArticleId IdType="pubmed">24356805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kasap B, Çarman KB, Yiş U. A case of acute post-streptococcal glomerulonephritis that developed posterior reversible encephalopathy syndrome. Turk Pediatri Ars. 2014;49:348–352. doi: 10.5152/tpa.2014.430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5152/tpa.2014.430</ArticleId>
            <ArticleId IdType="pmc">PMC4462310</ArticleId>
            <ArticleId IdType="pubmed">26078688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar SR, Kumar M, Shobhana S, Sampath S, Kasthuri RK. Posterior reversible encephalopathy syndrome unmasking acute glomerulonephritis. J Clin Diagn Res. 2014;8:177–178. doi: 10.7860/JCDR/2014/6465.3818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7860/JCDR/2014/6465.3818</ArticleId>
            <ArticleId IdType="pmc">PMC3939544</ArticleId>
            <ArticleId IdType="pubmed">24596763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaki SA, Shanbag P. Unusual presentation of poststreptococcal glomerulonephritis as posterior reversible encephalopathy syndrome. J Pediatr Neurosci. 2014;9:42–44. doi: 10.4103/1817-1745.131484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/1817-1745.131484</ArticleId>
            <ArticleId IdType="pmc">PMC4040032</ArticleId>
            <ArticleId IdType="pubmed">24891903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdool K, Ramcharan K, Bhagwandass N, Persad N, Temull V, Seegobin K, Mike C. Posterior reversible encephalopathy syndrome and acute post-streptococcal glomerulonephritis mimicking breakthrough seizures. Neurol Int. 2015;7:5971. doi: 10.4081/ni.2015.5971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/ni.2015.5971</ArticleId>
            <ArticleId IdType="pmc">PMC4508544</ArticleId>
            <ArticleId IdType="pubmed">26294945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasubramaniyan S, Selvamuthukumaran S, Krishnamoorthy K. Posterior reversible encephalopathy syndrome in post-streptococcal glomerulonephritis. J Assoc Physicians India. 2015;63:71–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26710406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuoni C, Vierucci F, Cesaretti G, Saggese G (2015) Poststreptococcal acute glomerulonephritis presenting as posterior reversible encephalopathy syndrome in an eleven-year-old boy. Minerva Pediatr 67:531–533</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26530495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kostopoulou E, Bertzouanis A, Charalampous E, Varvarigou A. Posterior reversible encephalopathy syndrome (PRES) presenting with status epilepticus in the context of post-streptococcal glomerulonephritis. J Infect Dis Med. 2017;2:107. doi: 10.4172/2576-1420.1000107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/2576-1420.1000107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reyes HA, Witsch J, Sueldo C, Hong J (2017) Posterior reversible encephalopathy in an adult patient with poststreptococcal glomerulonephritis. BMJ Case Rep 2017:bcr2017220043. 10.1136/bcr-2017-220043</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5534978</ArticleId>
            <ArticleId IdType="pubmed">28416474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanafy E, Alshareef D, Osman S, Al Jabri A, Nazim F, Mahmoud G. Posterior reversible encephalopathy syndrome secondary to asymptomatic poststreptococcal glomerulonephritis in a child with sickle cell anemia: a case report. J Med Case Rep. 2018;12:24. doi: 10.1186/s13256-017-1559-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13256-017-1559-x</ArticleId>
            <ArticleId IdType="pmc">PMC5793438</ArticleId>
            <ArticleId IdType="pubmed">29386039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasheed J, Hassan R, Zafar F (2018) Posterior reversible encephalopathy syndrome secondary to acute poststreptococcal glomerulonephritis in a 12-year-old girl. J Coll Physicians Surg Pak 28:80–81. 10.29271/jcpsp.2018.01.80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29290203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doğan CS, Aksoy GK, Kutluk MG, Özkan MB. Posterior reversible encephalopathy syndrome in an adolescent with acute poststreptococcal glomerulonephritis. J Pediatr Neurol. 2020;18:144–147. doi: 10.1055/s-0039-1683999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0039-1683999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller JB, Suchdev K, Jayaprakash N, Hrabec D, Sood A, Sharma S, Levy PD. New developments in hypertensive encephalopathy. Curr Hypertens Rep. 2018;20:13. doi: 10.1007/s11906-018-0813-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11906-018-0813-y</ArticleId>
            <ArticleId IdType="pubmed">29480370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>August P. Hypertensive encephalopathy: what’s in a name? J Am Soc Hypertens. 2016;10:404–405. doi: 10.1016/j.jash.2016.03.189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jash.2016.03.189</ArticleId>
            <ArticleId IdType="pubmed">27067368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lava SAG, Peeters GG, Bianchetti MG, Goeggel Simonetti B, Simonetti GD, Milani GP. Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura. Rheumatol Int. 2017;37:461–463. doi: 10.1007/s00296-016-3577-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-016-3577-1</ArticleId>
            <ArticleId IdType="pubmed">27770226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelke C, Schulte-Mecklenbeck A, Pawlitzki M, Rolfes L, Räuber S, Gross CC, Minnerup J, Meuth SG, Wiendl H, Ruck T. The innate immune response characterizes posterior reversible syndrome. J Clin Immunol. 2021 doi: 10.1007/s10875-021-01033-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10875-021-01033-3</ArticleId>
            <ArticleId IdType="pmc">PMC8310851</ArticleId>
            <ArticleId IdType="pubmed">33844127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solh Z, Taccone MS, Marin S, Athale U, Breakey VR. Neurological PRESentations in sickle cell patients are not always stroke: a review of posterior reversible encephalopathy syndrome in sickle cell disease. Pediatr Blood Cancer. 2016;63:983–989. doi: 10.1002/pbc.25932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.25932</ArticleId>
            <ArticleId IdType="pubmed">26871763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seeman T, Hamdani G, Mitsnefes M. Hypertensive crisis in children and adolescents. Pediatr Nephrol. 2019;34:2523–2537. doi: 10.1007/s00467-018-4092-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-018-4092-2</ArticleId>
            <ArticleId IdType="pubmed">30276533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol 28:1320–1327. 10.3174/ajnr.A0549</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7977645</ArticleId>
            <ArticleId IdType="pubmed">17698535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calvetta A, Martino S, von Vigier RO, Schmidtko J, Fossali E, Bianchetti MG. “What goes up must immediately come down!” Which indication for short-acting nifedipine in children with arterial hypertension? Pediatr Nephrol. 2003;18:1–2. doi: 10.1007/s00467-002-1010-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-002-1010-3</ArticleId>
            <ArticleId IdType="pubmed">12520323</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
